Therapeutic use of aerosolized S-nitrosoglutathione in cystic fibrosis
US6723703B2 · kind B2 · utility
32Cited by
7References
7Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 24, 2003 |
| Grant date | Apr 20, 2004 |
| Priority date | — |
| Expiry date | Mar 24, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to the treatment of cystic fibrosis that involves the administration of a nitrosylating agent, such as S-nitrosoglutathione or ethyl nitrite.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.